 Thanks to a blowout fourth quarter, a Los Angeles-area diagnostic and genetics company saw its shares soar to an all-time high. Fulgent Genetics Inc.NASDAQ:FLGT hit nearly 190 during the first week of February, but has since eased to just more than 100, perhaps over concerns about what the company has behind its booming Covid-19 testing business. 